Gene expression profiling test expands to assess colon and prostate cancers

The high price of gene expression profiling – and the uneven coverage for it across this country – point to the hard choices ahead for provincial health departments as personalized cancer medicine moves from dream to day-to-day reality in oncologists’ offices and cancer clinics. Health officials always wrestle with what to pay for, but new assays that can tailor treatments for cancer, Canada’s number one killer, are upping the ante. Read more here.